We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: AAD-305
CAS No: 227006-55-5
Synonyms/Alias: 227006-55-5;N-Fmoc-N-(3-buten-1-yl)-glycine;2-[But-3-enyl(9H-fluoren-9-ylmethoxycarbonyl)amino]acetic acid;N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-(but-3-en-1-yl)glycine;2-[(but-3-en-1-yl)({[(9H-fluoren-9-yl)methoxy]carbonyl})amino]acetic acid;{but-3-en-1-yl[(9H-fluoren-9-ylmethoxy)carbonyl]amino}acetic acid;2-((but-3-en-1-yl)((((9H-fluoren-9-yl)methoxy)carbonyl))amino)acetic acid;F81049;EN300-1556550;Glycine, N-3-buten-1-yl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;861-876-5;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C21H21NO4 |
M.W/Mr. | 351.4 |
InChI | InChI=1S/C21H21NO4/c1-2-3-12-22(13-20(23)24)21(25)26-14-19-17-10-6-4-8-15(17)16-9-5-7-11-18(16)19/h2,4-11,19H,1,3,12-14H2,(H,23,24) |
InChI Key | IJBPAHPUQGXDLW-UHFFFAOYSA-N |
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
Required fields are marked with *
×Required fields are marked with *
×If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com